Clinical significance of melanoma antigen-encoding gene-1 (MAGE-1) expression and its correlation with poor prognosis in differentiated advanced gastric cancer

Annals of Surgical Oncology

Volumn 18, Issue 4, 2011, Pages 1195-1203

  Ogata, Kyoichi ^a   Aihara, Ryuusuke ^b   Mochiki, Erito ^a   Ogawa, Atsushi ^a   Yanai, Mitsuhiro ^a   Toyomasu, Yoshitaka ^a   Ando, Hiroyuki ^a   Ohno, Tetsuro ^a   Asao, Takayuki ^a   Kuwano, Hiroyuki ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SAISEIKAI MAEBASHI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOMA ANTIGEN 1;

ADULT; ADVANCED CANCER; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; STOMACH CANCER;

AGED; CELL DIFFERENTIATION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MELANOMA-SPECIFIC ANTIGENS; MIDDLE AGED; PROGNOSIS; STOMACH; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 79955819316     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1399-z     Document Type: Article

References (35)

1. van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 1991;254(5038):1643-7. (Pubitemid 21917508)
2. Chomez P, De Backer O, Bertrand M, De Plaen E, Boon T, Lucas S. An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res. 2001;61(14): 5544-51. (Pubitemid 32694940)
3. Lucas S, De Plaen E, Boon T. MAGE-B5, MAGE-B6, MAGEC2, and MAGE-C3: four new members of the MAGE family with tumor-specific expression. Int J Cancer. 2000;87(1):55-60. (Pubitemid 30368415)
4. Brasseur F, Marchand M, Vanwijck R, et al. Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors. Int J Cancer. 1992;52(5):839-41.
5. Yoshimatsu T, Yoshino I, Ohgami A, et al. Expression of the melanoma antigen-encoding gene in human lung cancer. J Surg Oncol. 1998;67(2):126-9. (Pubitemid 28109979)
6. Inoue H, Li J, Honda M, et al. MAGE-1 mRNA expression in gastric carcinoma. Int J Cancer. 1995;64(1):76-7.
7. Inoue H, Mori M, Honda M, et al. The expression of tumorrejection antigen "MAGE" genes in human gastric carcinoma. Gastroenterology. 1995;109(5):1522-5.
8. Honda T, Tamura G, Waki T, et al. Demethylation of MAGE promoters during gastric cancer progression. Br J Cancer. 2004;90(4):838-43. (Pubitemid 38406595)
9. Jung EJ, Kim MA, Lee HS, et al. Expression of family A melanoma antigen in human gastric carcinoma. AntiCancer Res. 2005;25(3B):2105-11. (Pubitemid 40904611)
10. Katano M, Nakamura M, Morisaki T, Fujimoto K. Melanoma antigen-encoding gene-1 expression in invasive gastric carcinoma: correlation with stage of disease. J Surg Oncol. 1997;64(3):195-201. (Pubitemid 27157407)
11. Suzuki S, Sasajima K, Sato Y, et al. MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer. Br J Cancer. 2008;99(2):350-6.
12. Inoue H, Mori M, Li J, et al. Human esophageal carcinomas frequently express the tumor-rejection antigens of MAGE genes. Int J Cancer. 1995;63(4):523-6.
13. Goodman JI, Watson RE. Altered DNA methylation: a secondary mechanism involved in carcinogenesis. Annu Rev Pharmacol Toxicol. 2002;42:501-25. (Pubitemid 34160534)
14. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3(6):415-28. (Pubitemid 34587077)
15. Tamura G. Genetic and epigenetic alterations of tumor suppressor and tumor-related genes in gastric cancer. Histol Histopathol. 2002;17(1):323-9. (Pubitemid 34116433)
16. De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci USA. 1996;93(14):7149-53. (Pubitemid 26243517)
17. De Plaen E, Arden K, Traversari C, et al. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics. 1994;40(5):360-9. (Pubitemid 24299325)
18. Takahashi K, Shichijo S, Noguchi M, Hirohata M, Itoh K. Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res. 1995;55(16):3478-82.
19. Sadanaga N, Nagashima H, Mashino K, et al. Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas. Clin Cancer Res. 2001;7(8): 2277-84. (Pubitemid 32751625)
20. Jang SJ, Soria JC, Wang L, et al. Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. Cancer Res. 2001;61(21):7959-63. (Pubitemid 33049388)
21. Marchand M, van Baren N, Weynants P, et al. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer. 1999;80(2):219-30. (Pubitemid 29001725)
22. Rogner UC, Wilke K, Steck E, Korn B, Poustka A. The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28. Genomics. 1995;29(3):725-31.
23. Sadanaga N, Nagashima H, Tahara K, Yoshikawa Y, Mori M. The heterogeneous expression of MAGE-3 protein: difference between primary lesions and metastatic lymph nodes in gastric carcinoma. Oncol Rep. 1999;6(5):975-7.
24. Japanese Gastric Cancer A. Japanese classification of gastric carcinoma-2nd English edition. Gastric Cancer. 1998;1(1): 10-24.
25. Nakamura K, Sugano H, Takagi K. Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gann. 1968;59(3):251-8.
26. Rimoldi D, Salvi S, Reed D, et al. cDNA and protein characterization of human MAGE-10. Int J Cancer. 1999;82(6):901-7. (Pubitemid 29384344)
27. Kim JH, Jung EJ, Lee HS, Kim MA, Kim WH. Comparative analysis of DNA methylation between primary and metastatic gastric carcinoma. Oncol Rep. 2009;21(5):1251-9.
28. Kuwahara A, Katano M, Nakamura M, Morisaki T, Miyazaki K, Fujimoto K. Expression of melanoma antigen-encoding gene-1 predicts lymph node involvement in early gastric carcinomas. Dig Dis Sci. 2001;46(2):262-7. (Pubitemid 32242673)
29. Jass JR, Filipe MI. The mucin profiles of normal gastric mucosa, intestinal metaplasia and its variants and gastric carcinoma. Histochem J. 1981;13(6):931-9. (Pubitemid 12073861)
30. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31-49.
31. Nakajima T, Enomoto S, Ushijima T. DNA methylation: a marker for carcinogen exposure and cancer risk. Environ Health Prev Med. 2008;13(1):8-15.
32. Maekita T, Nakazawa K, Mihara M, et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res. 2006;12(3 Pt 1):989-95. (Pubitemid 43259882)
33. Reis CA, David L, Correa P, et al. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res. 1999;59(5): 1003-7. (Pubitemid 29135958)
34. Tajima Y, Shimoda T, Nakanishi Y, et al. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology. 2001;61(3):212-20. (Pubitemid 34701536)
35. Waki T, Tamura G, Sato M, Motoyama T. Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples. Oncogene. 2003;22(26):4128-33. (Pubitemid 36819653)